Oncoimmunology

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.

Fotaki G, Jin C, Kerzeli IK, ..., Yu D, Essand M

Oncoimmunology 7 (3) e1397250 [2017-12-26; online 2017-12-26]

Affiliated researcher

Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses.

Fotaki G, Jin C, Ramachandran M, ..., Yu D, Essand M

Oncoimmunology 7 (3) e1395126 [2017-11-27; online 2017-11-27]

Affiliated researcher

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.

Cedervall J, Dragomir A, Saupe F, ..., Larsson A, Olsson AK

Oncoimmunology 6 (8) e1320009 [2017-04-20; online 2017-04-20]

Affiliated researcher

Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Espinoza JA, Jabeen S, Batra R, ..., Kristensen VN, Gromova I

Oncoimmunology 5 (12) e1248015 [2016-10-24; online 2016-10-24]

Affiliated researcher

Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.

Eissler N, Mao Y, Brodin D, ..., Kiessling R, Kogner P

Oncoimmunology 5 (12) e1232222 [2016-09-09; online 2016-09-09]

Affiliated researcher SciLifeLab Fellow Yumeng Mao

Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.

Moudra A, Hubackova S, Machalova V, ..., Hodny Z, Jonasova A

Oncoimmunology 5 (10) e1183860 [2016-05-13; online 2016-05-13]

Affiliated researcher